Here, we noted significantly augmented IL-9 production by cultured lung cells stimulated with aCD3/28 antibodies from the TU region in NSCLC as compared to the CTR and PT regions of these patients. This evidence concerns the gene IL9 and non-small cell lung carcinoma.